Dr. Khan will advance Evidation’s management in real-world information by driving the medical technique for direct-to-participant multimodal information assortment to gasoline AI-powered discovery and proof technology. Evidation, the chief in direct-to-participant real-world information and well being analysis, at the moment introduced the appointment of Dr. Ghazanfar Khan as Chief Medical Officer. A doctor and international…
Proprietary agentic AI mannequin transforms genomic and real-world information into actionable insights throughout the complete drug lifecycle Enables sooner improvement of breakthrough therapies, together with tumor-agnostic most cancers remedies, by a 360-degree view of the precision medication panorama Empowers scientific researchers throughout the life sciences and healthcare continuum to carry out large-scale information evaluation for the development…
Dr. Murphy to steer the continued scale up and growth of Bexorg’s totally built-in AI and whole-human mind platform centered on CNS ailments Bexorg, Inc., the primary built-in AI and whole-human mind platform firm reworking central nervous system (CNS) drug discovery and improvement, at the moment introduced that Sean Murphy, Ph.D., has joined the corporate…
Accumulus Technologies is happy to welcome business veteran Mervyn Hall to its govt management group as Chief Commercial Officer. Prior to becoming a member of Accumulus, Hall served as the Senior Vice President of Commercial at Aetion, which was acquired by Datavant in July 2025. Before Aetion, Hall served as Chief Operating Officer and Board…
Complete Genomics, a number one innovator in genomic sequencing, right this moment introduced a collaboration with SOPHiA GENETICS (NASDAQ: SOPH), a worldwide chief in AI-driven precision medication, to launch and co-market MSK-ACCESS® and MSK-IMPACT® powered with SOPHiA DDM on Complete Genomics’ DNBSEQ-T1+ sequencing platform. The firms purpose to broaden entry to precision oncology testing by providing the best-in-class…
Eight internationally famend consultants be a part of Bioptimus to pioneer large-scale basis fashions that may rework science and drugs Bioptimus, the pioneering start-up constructing the world’s first common basis mannequin for biology, at the moment introduced the formation of its Scientific Advisory Board (SAB), bringing collectively among the most influential minds on the intersection…
– Strategic acquisition of UK genomics chief Congenica reinforces SeqOne market place and footprint – servicing over 160 labs in 30+ international locations – The acquisition creates the biggest international ‘software program pure participant’ within the scientific genomics house, which can keep UK presence on the famend Wellcome Sanger Institute SeqOne, a pioneer in AI-driven genomic evaluation,…
Collaboration Extends World Attain of Excessive-Efficiency Genomic Sequencing on the UG 100 Platform Ultima Genomics, Inc., developer of the UG 100 next-generation sequencing (NGS) platform, and Gene by Gene, a number one world supplier of superior genetic testing and genomic companies, at present introduced a partnership to broaden worldwide entry to high-quality, cost-effective DNA sequencing. By…
BeginNGS to display newborns for a couple of thousand treatable genetic issues Rady Kids’s Institute for Genomic Drugs (RCIGM®) at this time introduced an settlement with Sidra Drugs, a world-class specialty healthcare group for girls, youngsters and younger folks within the State of Qatar, to collaborate on implementing RCIGM’s genome-based new child screening program, BeginNGS (pronounced “beginnings”). Sidra…
Company reiterates its precision prevention commitment with latest expansion of its high-stakes cancer pledge—now targeting lung cancer, the world’s deadliest cancer. In a bold move to challenge one of the deadliest cancers worldwide , Human Longevity, Inc. (HLI) is expanding its high-profile $1 million pledge to include late-stage lung cancer—sending a clear signal that precision prevention is not just a promise, but a guarantee. Reflecting HLI’s…